Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Knighty Tin who wrote (29314)	6/24/1998 11:13:00 AM
From: Exacctnt	Read Replies (1) \| Respond to of 132070

Mike, Thanks for your reply. I think you need to pick up another third in GENZL. When you announced your last purchase, it lifted the stock. <g> Regards, Bob

To: Knighty Tin who wrote (29314)	6/24/1998 11:22:00 AM
From: Exacctnt	Read Replies (1) \| Respond to of 132070

Mike, Just picked up this item. NEW YORK, June 24 (Reuters) - Raymond James said on Wednesday it started coverage on shares of Genzyme Corp. with an accumulate rating and Genzyme Transgenics Corp. (GZTC - news) with a buy raing. Hey Raymond James, what about GENZL? Regards, Bob

To: Knighty Tin who wrote (29314)	6/24/1998 12:06:00 PM
From: yard_man	Read Replies (1) \| Respond to of 132070

Article in the WSJ about "archaic rules" of Chile's Bolsa. This may close to the bottom for Chile.